D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
about
Dopamine D4 receptor oligomerization--contribution to receptor biogenesisRole of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophreniaHeteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophreniaSchizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerizationLentiviral-mediated gene delivery reveals distinct roles of nucleus accumbens dopamine D2 and D3 receptors in novelty- and light-induced locomotor activityStructure-guided development of heterodimer-selective GPCR ligandsFunctional characterization of G-protein-coupled receptors: a bioinformatics approach.Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout miceSubapical localization of the dopamine D3 receptor in proximal tubules of the rat kidney.The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic DrugsDominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys.Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration.Design strategies for bivalent ligands targeting GPCRs.Targeting the dopamine D3 receptor: an overview of drug design strategies.Dopamine and serotonin receptor binding and antipsychotic efficacy.Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+.Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.Signaling mechanisms of the D3 dopamine receptor.Functional Characterisation of Eel Dopamine D2 Receptors and Involvement in the Direct Inhibition of Pituitary Gonadotrophins.Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and DiseaseDopamine receptor homooligomers and heterooligomers in schizophreniaHeteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevanceThyroid hormone and adrenergic signaling interact to control pineal expression of the dopamine receptor D4 gene (Drd4).Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuseThe role of dopaminergic signalling during larval zebrafish brain development: a tool for investigating the developmental basis of neuropsychiatric disorders.Dopamine and renal function and blood pressure regulation.Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin ReceptorsDopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.Role of iso-receptors in receptor-receptor interactions with a focus on dopamine iso-receptor complexes.Synthesis and dual D2 and 5-HT1A receptor binding affinities of 5-piperidinyl and 5-piperazinyl-1H-benzo[d]imidazol-2(3H)-ones.Neurochemical evidence supporting dopamine D1-D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulationCell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization.ALG-2 interacting protein AIP1: a novel link between D1 and D3 signalling.Abnormalities of Dopamine D3 Receptor Signaling in the Diseased Brain.Regulation of G Protein-Coupled Receptors by Ubiquitination.Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer.Receptor oligomerization: from early evidence to current understanding in class B GPCRs.Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder.
P2860
Q24293127-9C7F65CA-9C24-48ED-9B6A-4A06E2F461E6Q24302099-EB33EF69-5533-4FB5-9488-7B9CC43D9C9BQ24630645-09902190-B034-486E-AFBE-F7F86CF61A5DQ24632803-21A65F9A-1DA7-49FF-B577-BCAB2A81CB23Q28567232-4FDE2820-B546-4DE5-9DB8-FC29E3B562BCQ28579950-D9C2084F-FFD4-4DF3-BCA1-FA537C084CA0Q28828634-BDA8CB21-C5E4-4681-9ABE-29FEF56A7070Q30009384-0FFBE4FB-9A95-4B43-82C6-F4ACF60EA90CQ30412976-25CA89DB-8F03-47F4-8D6E-AFACFA4F1A9FQ31131022-3C655CE8-2E94-45E7-93ED-7CDFDF9D2EA1Q33707895-457346CB-0E3C-46B6-BC5C-2D574A29B870Q33788002-33ADF0DA-395E-408E-8AA7-363CF89CE058Q33983589-F40CCFE6-5C71-4FE6-97EB-10D830FCCA1CQ34180510-8937AA7F-22CF-46E6-94C7-1E3912C8A079Q34524556-D892C808-517A-48DD-9CD7-04A66FB7AEFBQ34605995-8197263D-58A1-4D55-BF7A-57A00D43973AQ35147150-2FF89C6B-B160-422D-BC74-8AFE815758D9Q35669960-EC53506A-4144-4392-96B2-FB67A7808012Q35742020-C817606D-3EBF-47C0-A00E-3CE7F93D1324Q35936704-B8F61F56-24A7-4A51-8F3A-CD298674DC74Q36084333-A4C75510-71D6-4E20-B991-A97D6E56D6FAQ36300230-6FBC68BC-0D30-4E74-B91D-4C5FEF006077Q37242424-6498223B-3D13-4639-82FA-BDD78809AF2AQ37379456-AEE070BD-E3ED-4B90-928E-566A012DEB4BQ37438782-6B949648-1904-4E69-9905-163D6FFFDC08Q37680038-790461E8-20D4-486C-A624-C60AE52621DAQ37880098-F17327D3-2DA4-4C86-8F5E-96CB480ABDD6Q38111703-B5E17ADE-FA30-4D54-A6A4-08353D54E681Q38166623-4036F038-0A89-40B2-8771-FB29CA636E44Q38285126-7EA2710B-2C4B-4215-BB49-E41FC73819CDQ38595178-435F4D14-A23B-41FA-AC95-229F1513D1EEQ39181392-1A4DE2C5-5438-4C70-AD49-370CB3EA8201Q39405720-193D1846-B22A-49EE-9227-BDA551DDC913Q39957511-DA9D3130-B560-446A-BAF0-4309356D439EQ39996415-82A51E93-D1EF-4B6D-98DF-89F89269F603Q41456216-EC9C21E1-E2E0-425D-AFE0-8A69CB9538F1Q42009313-EE82E849-28E2-4129-A9A2-22C220E29571Q42046489-0EE1AB01-A7F1-46F5-8299-E9D373B8440BQ42567375-654C9EBC-5A3A-473C-AA84-0864D7A40F0BQ43645946-C5D65BA9-10C7-4CB8-A399-133FF734D497
P2860
D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
@en
D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
@nl
type
label
D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
@en
D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
@nl
prefLabel
D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
@en
D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
@nl
P2093
P2860
P356
P1476
D2/D3 dopamine receptor heterodimers exhibit unique functional properties.
@en
P2093
Corsini GU
Levenson R
Schallmach E
Sokoloff P
P2860
P304
30308-30314
P356
10.1074/JBC.M102297200
P407
P577
2001-05-23T00:00:00Z